Stocks and Investing Stocks and Investing
Thu, August 3, 2023

Mark Breidenbach Reiterated (ALLO) at Buy and Held Target at $28 on, Aug 3rd, 2023


Published on 2024-10-28 05:26:40 - WOPRAI, Mark Breidenbach
  Print publication without navigation


Mark Breidenbach of Oppenheimer, Reiterated "Allogene Therapeutics, Inc." (ALLO) at Buy and Held Target at $28 on, Aug 3rd, 2023.

Mark has made no other calls on ALLO in the last 4 months.



There are 6 other peers that have a rating on ALLO. Out of the 6 peers that are also analyzing ALLO, 1 agrees with Mark's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $7.5 on, Thursday, May 4th, 2023


These are the ratings of the 5 analyists that currently disagree with Mark


  • Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Decreased Target to $18 on, Wednesday, July 12th, 2023
  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Tuesday, June 20th, 2023
  • John Newman of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $35 on, Friday, June 16th, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $15 on, Monday, June 5th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $15 on, Thursday, May 4th, 2023
Contributing Sources